Table 3.
Mean toxicokinetic parameters of JBD0131 and DM131 in SD rat plasma following oral gavage of JBD0131
| Test compound | Days of administration | Sex | Dose (mg/kg) |
n | AUClast (h*ng/mL) | Cmax (ng/mL) | ||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||||
| JBD0131 | 1 | Female | 30 | 5 | 3000 | 721 | 251 | 17.4 |
| 120 | 5 | 7890 | 2130 | 522 | 83.9 | |||
| 480 | 5 | 26,300 | 20,600 | 802 | 104 | |||
| Male | 30 | 5 | 3650 | 255 | 239 | 16.1 | ||
| 120 | 5 | 8280 | 4550 | 425 | 18.4 | |||
| 480 | 5 | 18,700 | 12,100 | 643 | 95.4 | |||
| 28 | Female | 30 | 5 | 3490 | 440 | 223 | 11.5 | |
| 120 | 5 | 4860 | 307 | 358 | 44.1 | |||
| 480 | 5 | 8680 | 1600 | 448 | 66.3 | |||
| Male | 30 | 5 | 2390 | 130 | 174 | 17.8 | ||
| 120 | 5 | 3640 | 442 | 227 | 20 | |||
| 480 | 5 | 7930 | 2070 | 343 | 32.2 | |||
| DM131 | 1 | Female | 30 | 5 | 1210 | 274 | 87.6 | 11.7 |
| 120 | 5 | 1050 | 358 | 54.5 | 12.2 | |||
| 480 | 5 | 4960 | 4260 | 109 | 40.1 | |||
| Male | 30 | 5 | 1410 | 110 | 90.7 | 5.8 | ||
| 120 | 5 | 1970 | 1180 | 84.4 | 11.8 | |||
| 480 | 5 | 3130 | 2480 | 97.7 | 30.3 | |||
| 28 | Female | 30 | 5 | 882 | 179 | 50.6 | 4.71 | |
| 120 | 5 | 1650 | 291 | 94 | 13.6 | |||
| 480 | 5 | 2230 | 609 | 82.1 | 12.7 | |||
| Male | 30 | 5 | 643 | 135 | 40.4 | 5.64 | ||
| 120 | 5 | 1310 | 136 | 57.5 | 3.24 | |||
| 480 | 5 | 2700 | 973 | 88 | 18.7 | |||
AUClastarea under the plasma concentration–time curve from time zero to the last measurable concentration
Cmaxmaximum plasma concentration